Agenda
Download Full Agenda as PDF
Conference Host
Pamala Jacobson, PharmD, FCCP, Organizing Committee Chair
Wednesday, September 21, 2022
Wednesday, September 21, 2022
Clinical Case Workshop
Pharmacogenomic Cases and Applications to Patient Care
Moderator
Susie Long, PharmD // M Health Fairview
| 9:00-9:15 |
Welcome |
| 9:15-10:00 | Case Studies in Mental Health Tyler Stevens, PharmD // Essentia Health |
| 10:00-10:45 | Case Studies in Cardiology Magali Disdier-Moulder, PharmD // Mayo Clinic |
| 10:45-11:30 | Case Studies in Pediatrics David Gregornik, PharmD, BCOP // Children’s Minnesota |
| 11:30-12:30 | Break |
| 12:30-1:15 | Case Studies in Oncology Jai N. Patel, PharmD // Atrium Health |
| 1:15-1:45 | Case Studies in Bone Marrow Transplant Susie Long, PharmD // M Health Fairview |
| 1:45-2:30 | Case Studies in NSAIDs and Opioids Jessica Wright, PharmD // Mayo Clinic |
| 2:30-3:15 | Case Studies in PPIs Valentina Shakhnovich, MD // Children's Mercy Hospital & Clinics, Kansas City |
| 3:15-3:30 | Break |
| 3:30-4:15 | Case Studies in Pharmacogenomic Assays and Phenotype Calls Pawel Mroz, MD, PhD // M Health Fairview and University of Minnesota |
| 4:15-5:00 | Case Studies in CYP2D6 Phenoconversion Kelsey Cook, PharmD, BCPS // University of Florida |
| 5:00-5:15 | Concluding Remarks Pamala Jacobson, PharmD, FCCP // University of Minnesota |
Thursday, September 22, 2022
Thursday, September 22, 2022
Morning Session
The Value Proposition of Pharmacogenomics
Moderator
David Stenehjem, PharmD, BCOP // University of Minnesota
| 8:30-9:00 | Non-CE Presentation by Geneticure—Lack of Genetic Considerations May be Detrimental to Patients in Current Hypertensive Clinical Recommendations by Eric Snyder, PhD |
| 9:00-9:15 | Welcome |
| 9:15-10:15 | KEYNOTE ADDRESS | Demonstrating the Economic Value of Pharmacogenomics in Clinical Care: Moving Beyond Drug-Gene Associations Peter H. O'Donnell, MD // University of Chicago |
| 10:15-10:45 | Breaking the Economic Barrier in Pharmacogenomics Bijan J. Borah, PhD, MPhil // Mayo Clinic |
| 10:45-11:15 | Preventing Harm through Pharmacogenomics James M. Hoffman, PharmD // St. Jude Children’s Research Hospital |
| 11:15-11:45 | Cost of Pharmacogenomic Implementation at System Scale: Navigating the Financial and Human Investment Christine Formea, PharmD, BCPS, FCCP, FASHP // Intermountain Healthcare Pharmacy Services |
| 11:45-12:45 | Clinical Decision Support for Pharmacogenomics: To Buy or Build? Panel Discussion Benjamin Duong, PharmD // Nemours Children's Health Steven Johnson, PhD // University of Minnesota Rebecca A. Pulk, PharmD // Yale New Haven Health |
| 12:45-1:15 | Non-CE Presentation by OneOme—The Value of Combining PGx with Comprehensive Medication Management (CMM) by Ghada Elnashar, PharmD |
| 1:15-1:45 | Non-CE Presentation by Thermo Fisher Scientific—Implement Predictive Genomics Today, Improve Healthcare’s Tomorrow by David Hanna, PhD |
| 1:45-2:15 | Pharmacogenomics and the Payer Perspective Rachael Pearson, PharmD // Optum Genomics at UnitedHealth Group |
Afternoon Session
Medication Therapy Management and Pharmacogenomics
Moderator
Jeffrey Bishop, PharmD, BCPP, FCCP // University of Minnesota
| 2:15-2:45 | Developing CMM/MTM: Get the Medicines Right Ira Klein, MD, MBA, FACP // GTMRx Institute |
| 2:45-3:45 | Pharmacogenomics and MTM: Integration into My Practice—How I Do It Amina Abubakar, PharmD, AAHIVP // Avant Pharmacy and Wellness Jennifer (Chi-Fan) Hockings, PharmD, PhD, BCPS // Cleveland Clinic |
| 3:45-4:15 | Educating the Patient About Pharmacogenomics and Return of Results Philip Empey, PharmD, PhD // University of Pittsburgh School of Pharmacy |
| 4:15-4:45 | Local Coverage Determinations for Pharmacogenomic Testing and Reimbursement D. Max Smith, PharmD, BCPS // MedStar Health and Georgetown University School of Medicine |
Friday, September 23, 2022
Friday, September 23, 2022
Morning Session
Pharmacogenomics Updates for the Practitioner
Moderator
Robert J. Straka, PharmD, FCCP // University of Minnesota
| 8:45-9:00 | Welcome |
| 9:00-9:30 | The Increased Complexity of Pharmacogenomic Associations: What to Do about Contributions by Multiple Drug-Metabolizing Genes and Pharmacodynamic Genes Kelly E. Caudle, PharmD, PhD, BCPS, FCCP // St. Jude Children’s Research Hospital |
| 9:30-10:15 | Pharmacogenomic Guideline Update: SNRI and SSRI Jeffrey Bishop, PharmD, BCPP, FCCP // University of Minnesota |
| 10:15-10:45 | Pharmacogenomic Guideline Update: Beta Blockers Julio Duarte, PharmD, PhD, FAHA // University of Florida College of Pharmacy |
| 10:45-11:30 | Pharmacogenomic Guideline Update: NSAIDs and Clopidogrel Craig Lee, PharmD, PhD, FCCP, FAHA // UNC Eshelman School of Pharmacy |
| 11:30-12:00 | Pharmacogenomic Guideline Update: Statins Robert J. Straka, PharmD, FCCP // University of Minnesota |
| 12:00-12:30 | Non-CE Presentation by Illumina—Aligning Genomics to Healthcare: Pharmacogenomics by Jamal Mitchell, MS and Adam Hauge, MBA |
| 12:30-1:00 | Non-CE Presentation by Invitae—PGx in Practice: Lessons Learned from Pharmacist-Led Implementations by Jennifer Wick, PharmD, MPH, BCACP and Kristine Ashcraft, BS, MBA |
| 1:15-1:45 | Novel Education and Implementation Strategies in Pharmacogenomics David Stenehjem, PharmD, BCOP // University of Minnesota |
| 1:45-2:15 | Regulatory Issues Relevant to Pharmacogenomics Josiah Allen, PharmD // St. Elizabeth Healthcare |
| 2:15-2:45 | Development of a Telehealth Program for Pharmacogenomics Jonathan Neufeld, PhD // Great Plains Telehealth Resource and Assistance Center |
| 2:45-3:15 | Legal and Liability Implications of Pharmacogenomics for Physicians and Pharmacists Anthony P. Morreale, PharmD // Department of Veterans Affairs |
Afternoon Session
Pharmacogenomics in Underserved Populations
Moderator
Josiah Allen, PharmD // St. Elizabeth Healthcare
| 3:45-4:15 | Pharmacogenomic Implementation in Rural and Underserved Populations: Challenges and Solutions Erica Woodahl, PhD // University of Montana |
| 4:15-4:45 | Moving Beyond Eurocentric Pharmacogenetics to Improve Health Outcomes for All Akinyemi Oni-Orisan, PharmD, PhD, DABCP, CLS, AACC // University of California, San Francisco |
| 4:45-5:00 | Conclusion of Program Pamala Jacobson, PharmD, FCCP // University of Minnesota |